Abstract – Background: Renal Cell Cancer (RCC) is the most common extra-thyroid cancer metastasizing to the thyroid gland and has been responsible for 48.1% metastases of Non-Thyroid Malignancies (NTMs) to the thyroid in the past decade. Metastases to the thyroid gland have been reported in 1.4%-3% of patients undergoing thyroid surgery for thyroid malignancies. We systematically reviewed the literature from 1964 to 2016 and herein present our experience. Patients and Methods: The research was systematically performed on Pubmed, EMbase and Cochrane Library databases by entering the strings: “renal carcinoma AND thyroid metastasis” or “renal carcinoma AND thyroid metastases” or “hypernephroma AND thyroid metastasis (or metastases)”. Results: 175 cases were retrieved and 90 were included in the study since they fulfilled the inclusion criteria by reporting gender, age, latency of metastases presentation after nephrectomy, jugular vein infiltration and other sites of metastasis (when applicable). The mean age of thyroid metastases presentation is 64.4 years and the mean latency after a nephrectomy is 9.1 years (range 0-24). Fine needle aspiration biopsy (FNAB) failed to provide the correct diagnosis in 28.7% of patients with thyroid metastases from RCC. Conclusions: Given the long latency, RCC follow-up program should be longer than recommended at present and implemented with an ultrasound scan of the neck.
Metastases from renal cell cancer to the thyroid gland. a systematic review of 175 cases between 1964 and 2016 / D'Angelo, Francesco; Magistri, Paolo; Antolino, Laura; Socciarelli, Fabio; Olivieri, Tiziana; Canegallo, Fiorella; Bollanti, Lucilla; Aurello, Paolo; Di Benedetto, Fabrizio; Ramacciato, Giovanni. - In: WORLD CANCER RESEARCH JOURNAL. - ISSN 2372-3416. - 3:2(2016), pp. 1-7.
Metastases from renal cell cancer to the thyroid gland. a systematic review of 175 cases between 1964 and 2016
MAGISTRI, PAOLO;Di Benedetto, Fabrizio;
2016
Abstract
Abstract – Background: Renal Cell Cancer (RCC) is the most common extra-thyroid cancer metastasizing to the thyroid gland and has been responsible for 48.1% metastases of Non-Thyroid Malignancies (NTMs) to the thyroid in the past decade. Metastases to the thyroid gland have been reported in 1.4%-3% of patients undergoing thyroid surgery for thyroid malignancies. We systematically reviewed the literature from 1964 to 2016 and herein present our experience. Patients and Methods: The research was systematically performed on Pubmed, EMbase and Cochrane Library databases by entering the strings: “renal carcinoma AND thyroid metastasis” or “renal carcinoma AND thyroid metastases” or “hypernephroma AND thyroid metastasis (or metastases)”. Results: 175 cases were retrieved and 90 were included in the study since they fulfilled the inclusion criteria by reporting gender, age, latency of metastases presentation after nephrectomy, jugular vein infiltration and other sites of metastasis (when applicable). The mean age of thyroid metastases presentation is 64.4 years and the mean latency after a nephrectomy is 9.1 years (range 0-24). Fine needle aspiration biopsy (FNAB) failed to provide the correct diagnosis in 28.7% of patients with thyroid metastases from RCC. Conclusions: Given the long latency, RCC follow-up program should be longer than recommended at present and implemented with an ultrasound scan of the neck.File | Dimensione | Formato | |
---|---|---|---|
D'Angelo_Metastases_2016.pdf
Open access
Dimensione
1.94 MB
Formato
Adobe PDF
|
1.94 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris